Cover Image
Market Research Report
Product code 
1095850

Global In-Vitro Diagnostics (IVD) Market Analysis 2021-2031

Published: | Research Nester | 221 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global In-Vitro Diagnostics (IVD) Market Analysis 2021-2031
Published: May 11, 2022
Research Nester
Content info: 221 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global in-vitro diagnostics (IVD) market is anticipated to grow with a CAGR of 4.6% over the forecast period, i.e., 2022 - 2031. Factors such as the rising healthcare expenditure and the growing advancements in research in the field of medical sciences, followed by the surge in cases of coronavirus, along with other chronic and infectious diseases globally are anticipated to drive the growth of the market in the coming years. Additionally, the rising prevalence of infectious and chronic diseases is also expected to boost the market growth. The global in-vitro diagnostics (IVD) market is estimated to garner a revenue of about USD 135170 Million by the end of 2031, up from a revenue of more than USD 87230 Million in the year 2021.

The global in-vitro diagnostics (IVD) market is segmented into numerous segments which include segmentation by product, technology, application, end-user, and by region. By product, the market is segmented into reagents, instruments, and services. By the end of 2031, the reagents segment is projected to garner the largest revenue of close to USD 112160 Million. Additionally, in the year 2021, the segment garnered a revenue of around USD 71790 Million.

On the basis of regional analysis, the global in-vitro diagnostics (IVD) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region, out of which, the market in North America is projected to garner the largest revenue of near to USD 57180 Million by the end of 2031. Additionally, in the year 2021, the market generated a revenue of close to USD 36990 Million.

However, the operational barriers faced during conduction of diagnostic tests, along with dynamic regulatory landscape are predicted to be some of the major restraint factors for the market growth during the forecast period.

Some of the prominent industry leaders in the global in-vitro diagnostics (IVD) market that are included in our report are: Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Sysmex Corporation, Qiagen GmbH, bioMerieux SA, Danaher Corporation, Bio Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Exact Sciences Corporation, Becton, Dickinson and Company, and others.

Table of Contents

1. Market Definition

2. Assumptions & Acronyms

3. Research Methodology

4. Executive Summary

5. Market Dynamics

6. Value Chain Analysis

7. Regulatory & Standards Landscape

8. Industry Risk Analysis

9. Pricing Analysis by Product

10. Impact of COVID-19 on the Global In-Vitro Diagnostics (IVD) Market

11. Patent Analysis

12. Analysis on End-User of Global In-Vitro Diagnostics (IVD) Market

13. Investment Analysis

14. Industry Growth Outlook

15. Competitive Feature Analysis

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2021
  • 16.2. Company Names
    • 16.2.1. Abbott
      • 16.2.1.1. Detailed Overview
      • 16.2.1.2. Assessment of Key Offering
      • 16.2.1.3. Predictive Strategies & Positioning vs. Current Positioning
      • 16.2.1.4. Analysis on Growth Strategies
      • 16.2.1.5. Exhaustive Analysis on Key Financial Indicators
      • 16.2.1.6. Recent Developments
    • 16.2.2. Siemens Healthcare GmbH
    • 16.2.3. F. Hoffmann-La Roche Ltd.
    • 16.2.4. Eisai Co., Ltd.
    • 16.2.5. Kyowa Kirin Co., Ltd.
    • 16.2.6. Sysmex Corporation
    • 16.2.7. Qiagen GmbH
    • 16.2.8. bioMerieux SA
    • 16.2.9. Danaher Corporation
    • 16.2.10. Bio Rad Laboratories, Inc.
    • 16.2.11. Thermo Fisher Scientific Inc.
    • 16.2.12. Exact Sciences Corporation
    • 16.2.13. Becton, Dickinson and Company

17. Global In-Vitro Diagnostics (IVD) Market

  • 17.1. Market Overview
  • 17.2. By Value (USD Million)
  • 17.3. Market Segmentation Analysis 2021-2031
    • 17.3.1. By Product
      • 17.3.1.1. Reagents & Kits
      • 17.3.1.2. Instruments
        • 17.3.1.2.1. Semi-Automated Instruments
        • 17.3.1.2.2. Fully Automated Instruments
      • 17.3.1.3. Services
    • 17.3.2. By Technology
      • 17.3.2.1. Immunoassay Systems
      • 17.3.2.2. DNA Analytics/Sequencing
      • 17.3.2.3. Molecular Diagnostics
      • 17.3.2.4. Hematology
      • 17.3.2.5. Tissue Diagnostics
      • 17.3.2.6. Microbiology
      • 17.3.2.7. Others
    • 17.3.3. By Application
      • 17.3.3.1. Oncology
      • 17.3.3.2. Cardiology
      • 17.3.3.3. Autoimmune Diseases
      • 17.3.3.4. Neurology
      • 17.3.3.5. Infectious Diseases
      • 17.3.3.6. Gastroenterology
      • 17.3.3.7. Others
    • 17.3.4. By End-User
      • 17.3.4.1. Hospitals & Clinics
      • 17.3.4.2. Research Institutes
      • 17.3.4.3. Diagnostics Laboratories
      • 17.3.4.4. Others
    • 17.3.5. By Region
      • 17.3.5.1. North America
      • 17.3.5.2. Europe
      • 17.3.5.3. Asia Pacific
      • 17.3.5.4. Latin America
      • 17.3.5.5. Middle East & Africa

18. North America In-Vitro Diagnostics (IVD) Market

  • 18.1. Market Overview
  • 18.2. By Value (USD Million)
  • 18.3. Market Segmentation Analysis 2021-2031
    • 18.3.1. By Product
      • 18.3.1.1. Reagents & Kits
      • 18.3.1.2. Instruments
        • 18.3.1.2.1. Semi-Automated Instruments
        • 18.3.1.2.2. Fully Automated Instruments
      • 18.3.1.3. Services
    • 18.3.2. By Technology
      • 18.3.2.1. Immunoassay Systems
      • 18.3.2.2. DNA Analytics/Sequencing
      • 18.3.2.3. Molecular Diagnostics
      • 18.3.2.4. Hematology
      • 18.3.2.5. Tissue Diagnostics
      • 18.3.2.6. Microbiology
      • 18.3.2.7. Others
    • 18.3.3. By Application
      • 18.3.3.1. Oncology
      • 18.3.3.2. Cardiology
      • 18.3.3.3. Autoimmune Diseases
      • 18.3.3.4. Neurology
      • 18.3.3.5. Infectious Diseases
      • 18.3.3.6. Gastroenterology
      • 18.3.3.7. Others
    • 18.3.4. By End-User
      • 18.3.4.1. Hospitals & Clinics
      • 18.3.4.2. Research Institutes
      • 18.3.4.3. Diagnostics Laboratories
      • 18.3.4.4. Others
    • 18.3.5. By Country
      • 18.3.5.1. United States
      • 18.3.5.2. Canada

19. Europe In-Vitro Diagnostics (IVD) Market

  • 19.1. Market Overview
  • 19.2. By Value (USD Million)
  • 19.3. Market Segmentation Analysis 2021-2031
    • 19.3.1. By Product
    • 19.3.2. By Technology
    • 19.3.3. By Application
    • 19.3.4. By End-User
    • 19.3.5. By Country
      • 19.3.5.1. Germany
      • 19.3.5.2. United Kingdom
      • 19.3.5.3. France
      • 19.3.5.4. Italy
      • 19.3.5.5. Spain
      • 19.3.5.6. Russia
      • 19.3.5.7. Rest of Europe

20. Asia Pacific In-Vitro Diagnostics (IVD) Market

  • 20.1. Market Overview
  • 20.2. By Value (USD Million)
  • 20.3. Market Segmentation Analysis 2021-2031
    • 20.3.1. By Product
    • 20.3.2. By Technology
    • 20.3.3. By Application
    • 20.3.4. By End-User
    • 20.3.5. By Country
      • 20.3.5.1. China
      • 20.3.5.2. Japan
      • 20.3.5.3. South Korea
      • 20.3.5.4. Australia
      • 20.3.5.5. India
      • 20.3.5.6. Singapore
      • 20.3.5.7. Rest of APAC

21. Latin America In-Vitro Diagnostics (IVD) Market

  • 21.1. Market Overview
  • 21.2. By Value (USD Million)
  • 21.3. Market Segmentation Analysis 2021-2031
    • 21.3.1. By Product
    • 21.3.2. By Technology
    • 21.3.3. By Application
    • 21.3.4. By End-User
    • 21.3.5. By Country
      • 21.3.5.1. Brazil
      • 21.3.5.2. Argentina
      • 21.3.5.3. Mexico
      • 21.3.5.4. Rest of Latin America

22. Middle East & Africa In-Vitro Diagnostics (IVD) Market

  • 22.1. Market Overview
  • 22.2. By Value (USD Million)
  • 22.3. Market Segmentation Analysis 2021-2031
    • 22.3.1. By Product
    • 22.3.2. By Technology
    • 22.3.3. By Application
    • 22.3.4. By End-User
    • 22.3.5. By Country
      • 22.3.5.1. GCC
      • 22.3.5.2. Israel
      • 22.3.5.3. South Africa
      • 22.3.5.4. Rest of Middle East & Africa